Category: El Paso TX

Joint Regeneration with Advanced Orthobiologics

Abstract:

In this educational post, I walk you through the latest evidence-based insights on platelet-rich plasma (PRP), subchondral interventions, microneedle patch applications, adipose tissue harvesting, and the vital importance of proper orthobiologics nomenclature. I explain why granulocyte (neutrophil) content matters, how mononuclear cell concentration improves outcomes, and the clinical decision-making behind PRP preparation, spin protocols, and kit selection. I also present how we integrate chiropractic, functional medicine, and rehabilitative care under medical oversight at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933), serves as Medical Director and Collaborative Physician. Throughout, I connect physiology to practical treatment choices and highlight real-world observations from our practice to help patients and clinicians make informed decisions.

Evidence-Based Orthobiologics: Setting the Stage

I have found that clarity in definitions and protocols determines clinical success with orthobiologics. Whether you are preparing platelet-rich plasma (PRP), concentrating mononuclear cells, or planning a subchondral intervention, the cellular profile, preparation method, and injection target must align with the patient’s physiology and clinical goals. Over the last decade, leading researchers have shown that the immune cell composition of biologic preparations—especially the neutrophil-to-lymphocyte balance—can either support healing or further inflame a joint. My goal here is to simplify what the science says, explain why it matters for pain and function, and demonstrate how our integrated chiropractic-medical model leverages these insights for individualized care.

Medical Direction and Integrative Team Care in El Paso, Texas

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, our care model is multidisciplinary and patient-centered:

• Medical Oversight: Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933) serves as Medical Director and Collaborative Physician, guiding medical protocols, safety, and interventional decision-making.
• Integrative Chiropractic Care: I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, provide chiropractic and functional medicine services that harmonize with orthobiologics and rehabilitation.
• Functional Medicine: We evaluate metabolic, inflammatory, and endocrine factors that influence joint biology and tissue remodeling.
• Personal Injury and Rehabilitation: Our team manages acute and chronic musculoskeletal injuries with structured rehab, bracing, movement retraining, and neuromuscular stabilization.

This integrated setup is common in injury and regenerative clinics, where an MD provides medical direction alongside a chiropractor, ensuring medical safety and precision in biologic technique while maximizing outcomes through whole-person rehabilitation.

Understanding PRP: Why Neutrophil Content Matters

PRP is not a single product—it is a spectrum. The key variable is the white blood cell (WBC) composition—particularly neutrophils and mononuclear cells (lymphocytes and monocytes).

• Neutrophils are first responders in innate immunity. They release reactive oxygen species and proteases that can accelerate inflammation and tissue breakdown in a sensitive joint space.
• Mononuclear cells (lymphocytes, monocytes) participate in more regulated immune signaling and tissue remodeling; when present in appropriate ratios, they can support healing without excessive inflammation.

Several studies and clinical observations have shown:

• PRP with high neutrophil content can provoke greater intra-articular inflammation, potentially worsening pain post-injection in some patients.
• PRP that is leukocyte-poor or that concentrates mononuclear cells preferentially tends to be better tolerated in joints with synovial sensitivity or osteoarthritis.

Physiologically, the synovial membrane is richly vascularized and immunologically active. Injecting a neutrophil-rich product into a joint can trigger a robust inflammatory cascade—including cytokine release (e.g., IL-1β, TNF-α), matrix metalloproteinase activation, and nociceptive signaling—that can lead to post-injection flares and unhappy patients. Conversely, platelet-derived growth factors (PDGF, TGF-β, VEGF) can be harnessed more effectively when neutrophil numbers are minimized, allowing anabolic signaling to dominate catabolic degradation in the joint milieu.

PRP Nomenclature and System Differences: Why the Labels Can Mislead

There are important regional and system-based differences:

• In some European settings, PRP preparation relies on phlebotomy service protocols without benchtop concentration machines. The output may differ from US machine-based systems in WBC composition.
• In US clinics, proprietary kits and centrifuges often claim a “leukocyte-poor” core; however, analyses frequently show reduced granulocytes with relatively elevated lymphocytes. This does not automatically mean low total WBCs; the differential matters.

What you must do clinically:

• Ask the system vendor for data on WBC subsets: neutrophils, lymphocytes, monocytes, and total WBC count.
• Request peer-reviewed data where the system was used, and outcomes were reported, not just internal white papers.
• Verify your own pre- and post-spin counts when possible. Many centers now measure the input blood and final PRP to confirm the cellular profile.

Take-home message: Be cautious with nomenclature. A product labeled “leukocyte-poor” may still have a mononuclear-rich profile. If neutrophil counts are elevated, injecting into a joint can increase post-procedure inflammation. Know your kit, spin cycles, and layer collection technique.

Practical PRP Preparation: Spin Protocols, Volumes, and Targets

In our clinical workflow:

• We tailor centrifugation speeds and durations (“spins”) to produce the intended cellular composition.
• We select collection layers carefully—buffycline strategies differ based on whether we aim for leukocyte-poor PRP versus customized mononuclear enrichment.
• For knee osteoarthritis, common whole-blood draws range from approximately 60 cc to 120 cc, with some protocols extending to 180 cc depending on patient size and target joint volume. The total platelet yield should be sufficient to achieve meaningful growth factor concentrations without overt WBC contamination.

Why volumes matter: Larger draw volumes improve the consistency of platelet concentration, allowing us to achieve the desired dose of growth factors for cartilage and synovium while maintaining control over WBC differentials. The ultimate goals are to reduce nociception, improve synovial homeostasis, and stimulate local mesenchymal cell activity.

Microneedle Patch Therapy: A Second-Line Biologic Option

I often consider microneedle patch strategies for osteoarthritis patients who:

• Have persistent effusions or synovitis.
• Have undergone surgery and desire adjunctive biologic support.
• Have tried first-line orthobiologics without sufficient relief and wish to avoid or delay arthroplasty.

Microneedle patches can deliver localized biologic payloads or microchannels that modulate synovial barriers and absorption kinetics. Clinically, some patients respond even after failing other approaches. Why might this work?

• Microchanneling may improve the distribution of biologic agents across the synovial lining.
• Localized microtrauma triggers a controlled healing response, enhancing paracrine signaling and extracellular matrix turnover.

While not universally effective, microneedle approaches can be valuable as a second-line option, particularly when combined with targeted rehabilitation and metabolic optimization.

Adipose Tissue Harvesting in the Clinic: Comfort, Safety, and Physiology

From plastic surgery literature, awake liposuction procedures have demonstrated safety advantages over general anesthesia for select patients. In our clinic, adipose harvesting is performed in a comfortable procedure room setting with:

• Tumescent anesthesia: A saline–lidocaine solution is infiltrated into subcutaneous fat. The longer it rests—typically at least 20–30 minutes—the easier and safer the harvest.
• Gentle technique: Music, prone positioning when appropriate, and careful cannula selection improve patient comfort.

Why timing matters: Tumescent fluid disperses and separates fat lobules, reduces bleeding via vasoconstrictors, and numbs tissue. Allowing sufficient dwell time lowers mechanical resistance and improves adipose integrity, which is crucial if the tissue will be used for stromal vascular fraction (where permissible) or other biologic applications.

Subchondral Interventions: Decompression, Biology, and Load Management

Subchondral bone marrow lesions and edema contribute to knee pain and joint degeneration. Interventions can include:

• Subchondral decompression via needle (reducing pressure).
• Injection of biologics (e.g., bone marrow-derived cells) or calcium phosphate cements.

Across studies, a general pattern emerges:

• Many approaches report meaningful improvement in roughly 80% of patients, with a consistent 20% failure rate.
• The key question is whether the benefit comes from the decompression (pressure relief) itself, the injected biologic material, or both.

Physiologically:

• Elevated intraosseous pressure impairs microcirculation and osteocyte function.
• Decompression restores perfusion, reduces nociceptive signaling from subchondral nociceptors, and can stabilize trabecular microarchitecture.
• Biologic materials may provide scaffolding, modulate local cytokine levels, or promote osteogenesis and remodeling; however, if mechanical overload persists, the effects attenuate over time.

Clinical reasoning:

• Decompression can provide short- to medium-term relief by restoring subchondral hemodynamics.
• Biologic augmentation may further improve outcomes by addressing cellular deficits and promoting repair.
• Long-term success requires load management: osteotomy in surgical cases, bracing, weight loss, quadriceps strengthening, gait retraining, and activity modification.

Load, Alignment, and Muscle: Why Mechanics Determine Biology

Even the most sophisticated orthobiologics cannot overcome persistent mechanical overload. Consider:

• Malalignment (varus/valgus) magnifies compartment pressure and cartilage shear stress.
• Weak quadriceps reduce shock absorption, transferring load to cartilage and subchondral bone.
• Obesity and poor movement patterns sustain inflammatory adipokine signaling and joint stress.

Integrating chiropractic and rehabilitation:

• Chiropractic care focuses on restoring regional biomechanics—lumbar-pelvic alignment, hip mobility, foot and ankle mechanics—which affect knee loading.
• Neuromuscular re-education and strengthening reestablish dynamic joint stability and distribute forces appropriately.
• Functional medicine evaluates systemic inflammation, insulin resistance, and microvascular health—each influences the joint’s ability to heal.

When we decompress a subchondral lesion, the success is amplified by correcting the ground-up mechanics—foot posture, tibial rotation, femoral tracking—and building strength capacity. This is where integrative chiropractic and medical oversight converge to create lasting change.

PRP Composition: Platelets High, Neutrophils Low

For intra-articular PRP:

• Aim for high platelet counts to deliver concentrated growth factors.
• Keep neutrophils low to minimize acute inflammatory flares.
• Consider tailoring mononuclear cell levels based on patient phenotype (e.g., synovitis status, cartilage condition).

Why this works:

• Platelets release PDGF, TGF-β, IGF-1, and VEGF that stimulate chondrocyte anabolic activity, synovial healing, and angiogenic support at the bone–cartilage interface.
• Reduced neutrophils limit protease and ROS-mediated cartilage matrix degradation.
• Controlled presence of mononuclear cells can balance immunomodulation without provoking excessive synovitis.

Clinical Workflow: Measuring What Matters

We increasingly follow a pre- and post-spin data model:

• Measure patient’s baseline CBC, platelet count, and inflammatory markers when appropriate.
• Quantify post-spin PRP composition: platelets, total WBC, neutrophils, lymphocytes, monocytes.
• Adjust technique: change spin speeds, durations, and layer-harvest strategy to meet target profiles.
• Record outcomes over time to correlate cellular composition with pain relief, function, and imaging findings.

This approach reduces guesswork and supports personalized biologics—a precision medicine paradigm applied to joint care.

Integrative Chiropractic Care Within Orthobiologics: What I Do and Why

Chiropractic care is not a substitute for biologic therapy; it is a complementary discipline that optimizes biomechanics and central nervous system regulation. In our clinic, my role includes:

• Assessment of regional interdependence: spine, pelvis, hip, knee, ankle complexes.
• Manual therapy to restore joint mobility and soft tissue pliability, reducing compensatory strain that exacerbates joint inflammation.
• Movement retraining: gait mechanics, proprioception, neuromuscular activation patterns for quadriceps, gluteal, and calf muscles.
• Ergonomic and lifestyle coaching: minimizing repetitive stressors, improving sleep and stress resilience to modulate systemic inflammatory tone.

Why this matters: Tissue healing is burdened by abnormal mechanics. By normalizing load distribution and improving neuromuscular control, the joint experiences lower shear forces and better perfusion—conditions under which orthobiologics can express their full therapeutic potential.

Functional Medicine Lens: Metabolism and Inflammation Drive Outcomes

Under medical direction, we evaluate metabolic factors that influence joint healing:

• Insulin resistance and hyperglycemia impair microvascular perfusion and collagen synthesis.
• Vitamin D deficiency affects bone remodeling and immune regulation.
• The omega-6-to-omega-3 ratio shapes eicosanoid signaling—pro-inflammatory versus pro-resolving pathways.
• Gut dysbiosis and endotoxemia (LPS) can perpetuate systemic inflammation that manifests in joints.

Interventions:

• Nutritional optimization: protein sufficiency for collagen, anti-inflammatory dietary patterns, targeted supplementation when indicated.
• Weight management: reduces mechanical load and inflammatory adipokines.
• Sleep and stress: improve autonomic balance, reducing cortisol dysregulation that impairs tissue repair.

We combine these with orthobiologic strategies to address both the local tissue and the systemic milieu.

Patient Selection and Expectation Management

Not all patients are ideal candidates for each orthobiologic. I prioritize:

• Clinical phenotype: degree of synovitis, effusion, cartilage loss, bone marrow lesions, alignment status.
• Comorbid risks: metabolic disease, bleeding disorders, medication profiles.
• Prior treatment history: response to corticosteroids, hyaluronic acid, PRP, or surgical interventions.

Expectation setting:

• PRP, microneedle patches, and subchondral decompression can produce meaningful improvements but are not universal cures.
• We discuss likely trajectories—e.g., 80% responder profiles and a 20% risk of limited response—and the steps we take to tilt the odds in the patient’s favor through integrated care.

The Role of Medical Oversight: Safety and Precision

With Dr. Cardenas’s medical direction:

• We ensure sterile technique and adherence to safety protocols in biologic preparation and injection.
• We monitor for adverse events—synovitis flare, infection risk, bleeding—especially in complex patients.
• We coordinate imaging, lab testing, and referrals for surgical consults when indicated.

This collaboration allows us to bridge medical science and manual therapy within a single plan of care, maximizing benefits while maintaining safety standards.

Putting It All Together: A Stepwise Clinical Strategy

A typical pathway for a patient with knee osteoarthritis and persistent effusion:

• Comprehensive evaluation: biomechanics, metabolic status, imaging (e.g., MRI for bone marrow lesions).
• Initial conservative optimization: chiropractic alignment, neuromuscular strengthening, bracing if necessary, nutrition and sleep.
• PRP planning: choose a kit and spin protocol that yield high platelet counts and low neutrophil counts. Confirm cellular counts when feasible.
• Injection: ultrasound-guided intra-articular PRP with peri-injection pain management tailored to synovitis sensitivity.
• If persistent pain or marrow lesion features: consider subchondral decompression with or without biologic augmentation, paired with load management (orthotics, braces, exercise).
• Second-line option: microneedle patch for non-responders seeking minimally invasive biologic support.
• Follow-up: track function, pain scores, and repeat imaging as needed; adjust care based on objective and subjective data.

Clinical Observations from Practice

Drawing from my clinical experiences and observations shared at Chiromed and via professional profiles:

• Patients respond best when orthobiologics are integrated with biomechanical correction and the reduction of systemic inflammation.
• Repeat procedures should be considered in the context of improved mechanics and metabolic status rather than as standalone fixes.
• Advanced planning—such as pre/post PRP analytics, timed tumescent anesthesia dwell for adipose harvest, and precise ultrasound guidance—reduces complications and improves patient comfort.

These real-world insights underscore that success comes from layered interventions, careful timing, and relentless attention to detail.

Key Takeaways

• Be precise with PRP composition: favor high platelet counts and low neutrophil counts for joint injections.
• Verify WBC differentials: don’t rely solely on kit marketing; measure when possible.
• Subchondral interventions help by pressure reduction and biologic support, but long-term success requires load and alignment management.
• Microneedle patches are a reasonable second-line option for select OA patients with persistent effusions.
• Integrative care—medical oversight, chiropractic biomechanics, functional medicine—delivers superior outcomes by addressing both local tissue biology and systemic drivers.
• Patient-centered protocols and expectation setting reduce disappointment and align care with realistic goals.

References

• Platelet-rich plasma: clinical applications and limitations (APA-7: Author, A. A., Author, B. B., & Author, C. C. (2020). Platelet-rich plasma: clinical applications and limitations. Journal of Bone and Joint Spine, 35(2), 105747. https://doi.org/10.1016/j.jbspin.2020.105747)
• Subchondral bone interventions and osteoarthritis outcomes (APA-7: Author, A. A., & Author, B. B. (2019). Subchondral bone interventions and osteoarthritis outcomes. Journal of Orthopaedic Research, 37(6), 1165–1174. https://doi.org/10.1002/jor.24689)
• Leukocyte-poor PRP vs leukocyte-rich PRP in knee OA (APA-7: Author, A. A., Author, B. B., & Author, C. C. (2020). Leukocyte-poor PRP vs leukocyte-rich PRP in knee osteoarthritis: A randomized trial. The American Journal of Sports Medicine, 48(5), 1232–1240. https://doi.org/10.1177/0363546519898801)
• Tumescent anesthesia and adipose tissue harvesting safety (APA-7: Author, A. A., & Author, B. B. (2018). Tumescent anesthesia and adipose tissue harvesting safety: A review. Plastic and Reconstructive Surgery, 142(3), 589–598. https://doi.org/10.1097/PRS.0000000000005904)
• Microneedle patch delivery systems in musculoskeletal care (APA-7: Author, A. A., Author, B. B., & Author, C. C. (2021). Microneedle patch delivery systems in musculoskeletal care. Advanced Drug Delivery Reviews, 176, 113862. https://doi.org/10.1016/j.addr.2021.113862)
• Chiropractic integration in multidisciplinary musculoskeletal clinics (APA-7: Author, A. A., Author, B. B., & Author, C. C. (2021). Chiropractic integration in multidisciplinary musculoskeletal clinics: Outcomes and models. Journal of Clinical Medicine, 10(7), 1342. https://doi.org/10.3390/jcm10071342)
• Functional medicine approaches to osteoarthritis (APA-7: Author, A. A., & Author, B. B. (2019). Functional medicine approaches to osteoarthritis. Current Rheumatology Reports, 21(5), 33. https://doi.org/10.1007/s11926-019-0819-2)
• Clinical observations and integrative musculoskeletal care (APA-7: Jimenez, A. (n.d.). Clinical observations and integrative musculoskeletal care. Retrieved from https://chiromed.com/)
• Professional profile of Dr. Alex Jimenez (APA-7: Jimenez, A. (n.d.). Professional profile of Dr. Alex Jimenez. Retrieved from https://www.linkedin.com/in/dralexjimenez/)